John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy
Anderson profiles John A. Galloway, pharmaceutical physician and leader in diabetes therapy. Galloway has been that leader, whose clinical curiosity, insights, dedication, and commitment to others brought insulin therapy from the impurified, low-potency animal insulins to the modern insulins of toda...
Gespeichert in:
Veröffentlicht in: | Diabetes care 2018-12, Vol.41 (12), p.2448-2452 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Anderson profiles John A. Galloway, pharmaceutical physician and leader in diabetes therapy. Galloway has been that leader, whose clinical curiosity, insights, dedication, and commitment to others brought insulin therapy from the impurified, low-potency animal insulins to the modern insulins of today. Born in Omaha, Nebraska, in 1928, Galloway moved to Washington, DC, and graduated from St. Albans School in 1946 and then from the University of Pennsylvania in Philadelphia in 1950 with a BA in English and Pre-Med. Galloway became Director of Clinical Diabetes at the Lilly Clinic (Lilly Laboratories for Clinical Research), then located at Wishard Memorial Hospital on the campus of the Indiana University School of Medicine, where he was appointed Associate Professor. |
---|---|
ISSN: | 0149-5992 1935-5548 |
DOI: | 10.2337/dci18-0042 |